Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04257123 · ClinicalTrials.gov registry record · NA
SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)
A NA study of Appetitive Behavior, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04257123 is a NA study of Appetitive Behavior that has completed, run by Purdue University. The registered enrollment target is 31 participants, below the 54-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04257123, a NA study of Appetitive Behavior, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
A recent clinical trial demonstrated the efficacy of Gelesis100 use for weight loss (Obes 2019;27:205-216). The present trial is designed to explore the mechanisms by which it may work, i.e. by suppressing hunger, altering food intake and/or altering the efficiency of energy extraction from food.
Conditions Studied
Interventions
- OTHER Placebo
- DEVICE Gelesis100
Study Locations (1)
Indiana
- Purdue Univeristy - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-01-07 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04257123
The ClinicalTrials.gov registry entry for NCT04257123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 54-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (43% lower). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Appetitive Behavior appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04257123 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04257123 about?
NCT04257123 is a clinical study titled "SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)". A recent clinical trial demonstrated the efficacy of Gelesis100 use for weight loss (Obes 2019;27:205-216). The present trial is designed to explore the mechanisms by which it may work, i.e. by suppressing hunger, altering food intake and/or altering the efficiency of energy extraction from food.
What is the current status of trial NCT04257123?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2020-01-07. Estimated completion is 2021-12-31.
What conditions does trial NCT04257123 study?
This clinical trial studies the following conditions: Appetitive Behavior.
What interventions are being tested in trial NCT04257123?
The interventions under investigation include: Placebo (OTHER), Gelesis100 (DEVICE).
Who is sponsoring clinical trial NCT04257123?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04257123 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Appetitive Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Food for Thought: Executive Functioning Around Eating Among Children
RECRUITING · NA
-
Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
Whole Grains, Gastric Emptying and Glycemic Response
COMPLETED · NA
-
Barley Beta-glucan, Glycemic Control, and Appetite
COMPLETED · NA
-
Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.